Simulect pediatric IV injection 10 mg, manufactured by Novartis Pharma, contains Basiliximab (genetical recombination) and is an injectable drug supplied as 10mg x 1 bottle (YJ code: 6399418D2020). This immunosuppressant is used to prevent acute organ rejection in pediatric renal transplant patients.
Simulect pediatric IV injection 10 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →